Table 1 AL Staging according to the revised Mayo AL staging tool [55]
From: Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
Number of abnormal laboratory tests | Stage (according to revised staging system) | Median Overall Survival (months) | 5-year Survival |
|---|---|---|---|
0 | I | 94.1 | 59% |
1 | II | 40.3 | 42% |
2 | III | 14 | 20% |
3 | IV | 5.8 | 14% |